Literature DB >> 11201889

Whole blood assays for interferon-gamma: practicalities and potential for use as diagnostic tests in the field.

H M Dockrell1, G F Black, R E Weir, P E Fine.   

Abstract

Recent years have seen the introduction of a number of whole-blood assays, in which unseparated heparinized blood is stimulated with antigen either overnight or for as long as 6 days, and cytokine production is measured in the plasma or supernatant. These assays have potential for use in the field as immunodiagnostic assays, as they require only a small blood sample and basic laboratory facilities. Use of these assays in a large study of the immunological effects of BCG vaccination in Malawi has shown that the diluted blood, 6-day whole-blood assays is robust, and can be used to assess T-cell responses to both crude and recombinant antigens. If used with antigens specific to Mycobacterium leprae, these assays could be used to measure exposure of M. leprae within communities or populations, or to aid the early diagnosis of leprosy.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11201889     DOI: 10.5935/0305-7518.20000069

Source DB:  PubMed          Journal:  Lepr Rev        ISSN: 0305-7518            Impact factor:   0.537


  4 in total

1.  Evaluation of various cytokines elicited during antigen-specific recall as potential risk indicators for the differential development of leprosy.

Authors:  L H Sampaio; A L M Sousa; M C Barcelos; S G Reed; M M A Stefani; M S Duthie
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-11-12       Impact factor: 3.267

2.  An adjuvant-modulated vaccine response in human whole blood.

Authors:  Jalil Hakimi; Ali Azizi; Salvador F Ausar; Stephen M Todryk; Nausheen Rahman; Roger H Brookes
Journal:  Hum Vaccin Immunother       Date:  2017-06-12       Impact factor: 3.452

3.  Enhancing sensitivity of detection of immune responses to Mycobacterium leprae peptides in whole-blood assays.

Authors:  Annemieke Geluk; Jolien J van der Ploeg-van Schip; Krista E van Meijgaarden; Susanna Commandeur; Jan W Drijfhout; Willemien E Benckhuijsen; Kees L M C Franken; Bernard Naafs; Tom H M Ottenhoff
Journal:  Clin Vaccine Immunol       Date:  2010-04-28

4.  Intracellular Cytokine Staining and Flow Cytometry: Considerations for Application in Clinical Trials of Novel Tuberculosis Vaccines.

Authors:  Steven G Smith; Kaatje Smits; Simone A Joosten; Krista E van Meijgaarden; Iman Satti; Helen A Fletcher; Nadia Caccamo; Francesco Dieli; Francoise Mascart; Helen McShane; Hazel M Dockrell; Tom H M Ottenhoff
Journal:  PLoS One       Date:  2015-09-14       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.